Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB01156_DB08920> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB01156_DB08920 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01156_DB08920 label "DDI between Bupropion and Zuclopenthixol decanoate - Bupropion, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if bupropion is initiated, discontinued or dose changed. [drugbank_resource:DB01156_DB08920]" assertion.
- drugbank_resource:DB01156_DB08920 identifier "drugbank_resource:DB01156_DB08920" assertion.
- drugbank_resource:DB01156_DB08920 title "DDI between Bupropion and Zuclopenthixol decanoate - Bupropion, a strong CYP2D6 inhibitor, may increase the serum concentration of zuclopenthixol by decreasing its metabolism. Consider alternate therapy or monitor for changes in the therapeutic and adverse effects of zuclopenthixol if bupropion is initiated, discontinued or dose changed." assertion.